| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Sep; 31(7):463-93.
Abstract | Full Citation |
| Han SS, Lee M, Park GH, et al.
Investigation of papulopustular eruptions caused by cetuximab treatment shows altered differentiation markers and increases in inflammatory cytokines. [JOURNAL ARTICLE]
Br J Dermatol 2009 Nov 9.
Abstract | Full Citation |
| Bonner JA, Harari PM, Giralt J, et al.
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. [JOURNAL ARTICLE]
Lancet Oncol 2009 Nov 6.
Abstract | Full Citation |
| Shimokawa T, Genma A
[antibody medicine directed against solid tumors] [Journal Article, Review]
Nippon Naika Gakkai Zasshi 2009 Aug 10; 98(8):1901-7.
Full Citation | Find Related Articles |
| Mendenhall WM, Riggs CE, Vaysberg M, et al.
Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma. [JOURNAL ARTICLE]
Head Neck 2009 Nov 5.
Abstract | Full Citation | Find Related Articles |
| Ray M, Salgia R, Vokes EE
The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer. [JOURNAL ARTICLE]
Oncologist 2009 Nov 5.
Abstract | Full Citation | Find Related Articles |
| Nishiyama M, Wada S
Docetaxel: its role in current and future treatments for advanced gastric cancer. [Journal Article]
Gastric Cancer 2009; 12(3):132-41.
Abstract | Full Citation |
| Larbouret C, Robert B, Bascoul-Mollevi C, et al.
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Tai CJ, Hsu CH, Wang FJ, et al.
Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer. [Letter]
Onkologie 2009 Nov; 32(11):685-6.
Full Citation | Find Related Articles |
| Laurent-Puig P, Cayre A, Manceau G, et al.
Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
   |
